Ventripoint Diagnostics Company Description
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide.
The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.
Contact Details
Address: 18 Hook Avenue Toronto, Alberta M6P 1T4 Canada | |
| Phone | 416 848 4156 |
| Website | ventripoint.com |
Stock Details
| Ticker Symbol | VPTDF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA92281P2008 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Hugh MacNaught | Chief Executive Officer, President and Director |
| Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. | Executive Chairman and Corporate Secretary |
| Jimmy Jeon CPA | Chief Financial Officer |
| Hirotaka Katagiri | Chief Technology Officer and Business Development Division Director |
| Matt Dobson | Marketing Director |
| Jim Graba | Application Specialist and Chief Trainer |